|
Market Cap (4-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.082 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 11 May 2021, 16:23. The announcement is not marked as price sensitive, and is 18 page(s) in length and 476.33kb in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.071% short sold according to ASIC data. It was ranked the 469th most shorted stock on the ASX. It remains ranked 590th as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| Appendix 2A - Fully Paid Ordinary Shares | 11 May 2021, 16:23 |
| Cleansing Notice under Section 708A | 11 May 2021, 16:21 |
| Imagion and Patrys collaborate on new cancer imaging agents | 3 May 2021, 9:49 |
| PAB: PAB and IBX collaborate on new cancer imaging agents | 3 May 2021, 9:49 |
You must be logged in to post a reply.
Imagion Biosystems 